UpHealth, Inc. Warrants exercisable for one share of Common Stock at an exercise price of $115.00 per share
UPH.WS
UPH.WS was delisted on the 27th of November, 2023.
15 hedge funds and large institutions have $39.3K invested in UpHealth, Inc. Warrants exercisable for one share of Common Stock at an exercise price of $115.00 per share in 2023 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and closing their positions.
25% more funds holding
Funds holding: 12 → 15 (+3)
42% less capital invested
Capital invested by funds: $67.8K → $39.3K (-$28.5K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RA
RFG Advisory
Birmingham,
Alabama
|
+$302 |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$160 |
| 3 |
Wells Fargo
San Francisco,
California
|
+$2 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Balyasny Asset Management
Chicago,
Illinois
|
-$309 |
| 2 |
CAC
Cowen and Company
New York
|
-$28 |
UPH.WS Hedge Fund Activity: Q3 2023 in Review
15 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in UpHealth, Inc. Warrants exercisable for one share of Common Stock at an exercise price of $115.00 per share (UPH.WS) for Q3 2023, worth a combined $39.3K — down 42% from $67.8K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new UPH.WS positions and 0 closed out — a net gain of 3 holders — while 0 added to existing stakes and 2 trimmed.
The largest buyer was RFG Advisory, opening a new position worth an estimated $302. The largest seller was Balyasny Asset Management, cutting an estimated $309.
- 15 institutional investors held UpHealth, Inc. Warrants exercisable for one share of Common Stock at an exercise price of $115.00 per share (UPH.WS) as of Q3 2023, up from 12 in Q2 2023.
- Funds reported $39.3K of UpHealth, Inc. Warrants exercisable for one share of Common Stock at an exercise price of $115.00 per share stock for Q3 2023, down 42% quarter-over-quarter.
- 3 funds opened new UpHealth, Inc. Warrants exercisable for one share of Common Stock at an exercise price of $115.00 per share positions in Q3 2023 and 0 closed out, a net change of +3 holders.
- The largest UpHealth, Inc. Warrants exercisable for one share of Common Stock at an exercise price of $115.00 per share buyer in Q3 2023 was RFG Advisory, an estimated $302 added.
- The largest UpHealth, Inc. Warrants exercisable for one share of Common Stock at an exercise price of $115.00 per share seller in Q3 2023 was Balyasny Asset Management, an estimated $309 sold.
Based on aggregated 13F filings for Q3 2023.